Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
KOSS Koss Corp
- Stocks
- Technology
- NASDAQ: KOSS
Price (delayed)
$4.99
Market cap
$46.79M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.08
Enterprise value
$43.85M
Predictive Oncology operates through three segments (Skyline, Helomics and Soluble Biotech), which contain four subsidiaries: Helomics, TumorGenesis, Skyline Medical and Soluble Biotech. Helomics applies artificial intelligence to its rich data
Highlights
Koss's EPS has increased by 33% YoY
Koss's net income has increased by 32% YoY
Key stats
What are the main financial stats of KOSS
Market
Valuations
Earnings
Shares outstanding
9.38M
Market cap
$46.79M
Enterprise value
$43.85M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.52
Price to sales (P/S)
3.76
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.53
Revenue
$12.43M
Gross profit
$4.83M
Operating income
-$1.62M
Net income
-$752,504
EBIT
-$737,305
EBITDA
-$507,053
Free cash flow
-$338,551
Per share
Balance sheet
Liquidity
EPS
-$0.08
EPS diluted
-$0.08
Free cash flow per share
-$0.04
Book value per share
$3.27
Revenue per share
$1.33
TBVPS
$3.98
Total assets
$37.3M
Total liabilities
$6.61M
Debt
$0
Equity
$30.68M
Working capital
$17.73M
Debt to equity
0
Current ratio
10.32
Quick ratio
7.41
Net debt/EBITDA
5.79
Margins
Efficiency
Dividend
EBITDA margin
-4.1%
Gross margin
38.8%
Net margin
-6.1%
Operating margin
-13%
Return on assets
-2%
Return on equity
-2.4%
Return on invested capital
-2.2%
Return on capital employed
-2.1%
Return on sales
-5.9%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
KOSS stock price
How has the Koss stock price performed over time
Intraday
-1.19%
1 week
2.25%
1 month
-16.83%
1 year
18.81%
YTD
-32.38%
QTD
5.72%
Financial performance
How have Koss's revenue and profit performed over time
Revenue
$12.43M
Gross profit
$4.83M
Operating income
-$1.62M
Net income
-$752,504
Gross margin
38.8%
Net margin
-6.1%
Koss's net income has increased by 32% YoY
Koss's net margin has increased by 31% YoY
Koss's gross profit has increased by 26% YoY and by 5% QoQ
The gross margin is up by 26% year-on-year and by 4% since the previous quarter
Price vs fundamentals
How does KOSS's price correlate with its fundamentals
Growth
What is Koss's growth rate over time
Valuation
What is Koss stock price valuation
P/E
N/A
P/B
1.52
P/S
3.76
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.53
Koss's EPS has increased by 33% YoY
KOSS's P/B is 46% below its 5-year quarterly average of 2.8 and 16% below its last 4 quarters average of 1.8
The stock's P/S is 18% below its last 4 quarters average of 4.6 and 6% below its 5-year quarterly average of 4.0
Efficiency
How efficient is Koss business performance
Koss's ROS has increased by 44% YoY and by 12% from the previous quarter
KOSS's ROIC is up by 44% YoY and by 12% QoQ
The company's return on equity rose by 31% YoY
Koss's ROA has increased by 31% YoY
Dividends
What is KOSS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for KOSS.
Financial health
How did Koss financials performed over time
The quick ratio is up by 12% since the previous quarter and by 10% year-on-year
The current ratio has grown by 3.5% from the previous quarter
Koss's debt is 100% lower than its equity
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.